PT  - JOURNAL ARTICLE
AU  - Adam, Philippe C.G.
AU  - de Coul, Eline L.M. Op
AU  - Zantkuijl, Paul
AU  - Bos, Hanna
AU  - Xiridou, Maria
AU  - Blom, Cor
AU  - Ketsuwan, Itsada
AU  - te Wierik, Margreet J.M.
AU  - David, Silke
AU  - de Wit, John B.F.
TI  - An assessment of rates and covariates of mpox diagnosis and vaccination provides evidence to refine eligibility criteria for mpox vaccination among gay, bisexual and other men who have sex with men in the Netherlands
AID  - 10.1101/2023.02.28.23286578
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.28.23286578
4099  - http://medrxiv.org/content/early/2023/03/02/2023.02.28.23286578.short
4100  - http://medrxiv.org/content/early/2023/03/02/2023.02.28.23286578.full
AB  - Background The 2022 multicountry mpox outbreaks predominantly affected gay, bisexual and other men who have sex with men (GBMSM) in non-endemic countries. Mpox vaccination is most effective if targeting GBMSM most at risk. It is unknown to what extent eligibility criteria for vaccination align with evidence on risk factors for mpox in GBMSM.Methods We conducted an online self-report survey among GBMSM in the Netherlands between 29 July and 30 August 30, 2022, corresponding to the first month of the Dutch mpox vaccination campaign. GBMSM were recruited via advertisements on social media and gay dating apps. Participants reported on their sexual behaviour, mpox diagnosis, and/or vaccination since the start of the outbreak.Results Of the 2,460 participants, 73 (3.0%) were diagnosed with mpox and 485 (19.7%) had been vaccinated. Using population sample weights, we estimated that, of the sexually active GBMSM population aged 18-80 years in the Netherlands, 1.1% had been diagnosed with mpox and 7.8% had been vaccinated. In multivariable logistic regression analyses, we found that current HIV-PrEP use, having ≥20 sex partners in the past 12 months and having sex in sex venues or at parties in the past two months were independent risk factors for mpox diagnosis.Conclusion This study provides novel evidence on risk factors for mpox amongst GBMSM in the Netherlands that has guided a refinement of eligibility criteria for mpox vaccination. The dynamics of any future mpox outbreaks are unknown and continued adjustment of vaccination eligibility may be required to achieve sustained elimination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe National Institute for Public Health and the Environment (RIVM) and Soa Aids Nederland provided financial support for this research study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for this study was granted on 25 July 2022 by the Faculty Research Ethics Board of the Faculty of Social and Behavioural Sciences, Utrecht University, The Netherlands (reference number: 22-0358).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors